Innoviva (INVA)
(Delayed Data from NSDQ)
$19.69 USD
+0.17 (0.87%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $19.67 -0.02 (-0.10%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth C Momentum C VGM
Income Statements
Fiscal Year end for Innoviva, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 310 | 331 | 392 | 337 | 261 |
Cost Of Goods | 43 | 14 | 0 | 0 | 0 |
Gross Profit | 268 | 318 | 392 | 337 | 261 |
Selling & Adminstrative & Depr. & Amort Expenses | 154 | -156 | 17 | 16 | 15 |
Income After Depreciation & Amortization | 114 | 474 | 375 | 321 | 246 |
Non-Operating Income | 99 | -171 | 89 | 51 | 5 |
Interest Expense | 19 | 16 | 19 | 18 | 19 |
Pretax Income | 194 | 287 | 445 | 354 | 233 |
Income Taxes | 14 | 67 | 76 | 60 | 42 |
Minority Interest | 0 | 6 | 103 | 69 | 34 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 180 | 220 | 369 | 294 | 191 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 180 | 214 | 266 | 224 | 157 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 152 | 495 | 398 | 343 | 265 |
Depreciation & Amortization (Cash Flow) | 38 | 22 | 23 | 22 | 19 |
Income After Depreciation & Amortization | 114 | 474 | 375 | 321 | 246 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 86.88 | 95.25 | 94.31 | 113.55 | 113.41 |
Diluted EPS Before Non-Recurring Items | 2.25 | 1.60 | 3.28 | 2.37 | 1.43 |
Diluted Net EPS (GAAP) | 2.20 | 2.37 | 2.87 | 2.02 | 1.43 |
Fiscal Year end for Innoviva, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 99.90 | 77.50 | 85.84 | 67.26 | 80.99 |
Cost Of Goods | 8.47 | 10.97 | 13.13 | 10.18 | 8.98 |
Gross Profit | 91.43 | 66.53 | 72.71 | 57.08 | 72.01 |
SG&A, R&D, and Dept/Amort Expenses | 36.74 | 40.73 | 35.19 | 39.14 | 43.49 |
Income After SG&A, R&D, and Dept/Amort Expenses | 54.69 | 25.80 | 37.52 | 17.94 | 28.52 |
Non-Operating Income | -88.16 | 25.17 | 29.63 | 72.41 | -18.34 |
Interest Expense | 5.80 | 5.85 | 5.95 | 4.40 | 4.38 |
Pretax Income | -39.28 | 45.12 | 61.20 | 85.95 | 5.81 |
Income Taxes | -4.59 | 8.59 | -0.33 | 3.91 | 4.53 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -34.69 | 36.53 | 61.53 | 82.05 | 1.28 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -34.69 | 36.53 | 61.53 | 82.05 | 1.28 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 62.53 | 84.53 | 85.00 | 86.16 | 65.49 |
Diluted EPS Before Non-Recurring Items | 0.68 | 0.46 | 0.76 | 0.98 | 0.08 |
Diluted Net EPS (GAAP) | -0.55 | 0.46 | 0.78 | 0.98 | 0.02 |